Melissa R. Gertler AssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail424-288-5314 Professional Biography Melissa Gertler is an associate in the Corporate Practice Group in the firm's Century City office. More Legal and Business Bylines From Melissa R. Gertler Elijah E. Cummins Lower Drug Costs Now Act: The Long and Winding Road to Drug Pricing Reform - (Posted On Wednesday, September 22, 2021) The Infrastructure Investment and Jobs Act: Potential Impact on Healthcare Policy and Spending - (Posted On Tuesday, August 24, 2021) Biden’s American Rescue Plan Follows Trend Toward Outpatient Setting, Increase in ASC Investment - (Posted On Thursday, May 20, 2021) Medi-Cal Rx: California to Transition Medi-Cal Pharmacy Benefits to Fee-For-Service - (Posted On Monday, January 11, 2021) CMS Announces New Geographic Direct Contracting Model: Letters of Interest Due by December 21, 2020 - (Posted On Tuesday, December 08, 2020) Eleventh Hour Rulemaking: HHS Eliminates Safe Harbor Protections for PBM Drug Rebates; and Creates Two New Safe Harbors for Point-of-Service Discounts and PBM Fixed-Fee Arrangements - (Posted On Wednesday, December 02, 2020) Texas v. California: SCOTUS Hears Oral Arguments About the Constitutionality of the ACA - (Posted On Tuesday, November 17, 2020) Primary Care First: CMS’s New Value-Based Approach to Primary Care - (Posted On Wednesday, November 11, 2020) The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry - (Posted On Friday, September 18, 2020) President Trump’s Executive Order Mandating the Purchase of U.S. Drugs Evokes Criticism - (Posted On Wednesday, August 19, 2020) Pagination Page 1 Next page Next › Current Legal Analysis Supreme Court Allows Trump Administration to Continue Plans to Reduce Federal Workforce by: Zachary V. Zagger Eighth Circuit Slams the Brakes on FTC’s Click-to-Cancel Rule by: Anita C. Marinelli , Kimberly A. Berger Australia: The Regulatory Developments for FY25 That Fund Managers Can’t Afford to Ignore by: Jim Bulling , Ben Kneebush FY 2026 H-1B Cap Filing Period Has Now Closed—What’s Next? by: Nicole Fink , Philip K. Sholts FDA Begins Public Comment Period on Method for Ranking Chemicals in Food for Post-Market Assessments by: Lynn L. Bergeson , Carla N. Hutton DOJ-HHS False Claims Act Working Group Outlines Healthcare Fraud Priorities by: Mary Jane Wilmoth President Trump Signs ‘One Big Beautiful Bill Act,’ Adopting Permanent Qualified Opportunity Zone Provisions with Rolling Deferral by: James O. Lang , Sanford C. Presant Drafting of Corporate and M&A Documents for 2025 Delaware General Corporation Law Amendments by: Nathan P. Emeritz , Diane N. Ibrahim When Saying Goodbye Is Not Forever: Ex-Spouses Who Continue as Business Partners After Divorce by: Ladd Hirsch Hot Dogs, Fireworks, and the One Big Beautiful Bill: What Employers Need to Know About the Employee Benefits and Executive Compensation Changes by: Tzvia Feiertag , Elliot Katz Texas Amends Restrictive Covenant Laws for Healthcare Providers by: David J. Clark Ninth Circuit Confirms Bristol-Myers’ Rule Applies to Notice in FLSA Collective Actions by: Matthew P.F. Linnabary , Robert J. Hingula NEPA in Flux: NEPA's Regulatory Retreat, the Rise of Agency Discretion, and Expedited NEPA for a Fee by: Rachael L. Lipinski , Molly A. Lawrence OSHA Issues NPRMs Affecting 26 Standards, Proposes Key Changes for Employers by: John Surma Most Law Firms Are Building on Leaky Foundations, and AI Will Expose It by: Mark Doble Upcoming Events Jul 9 2025 Employment Law in the US Jul 10 2025 Mandatory Roth Catch-up Jul 10 2025 Checkmate: Making the Right Moves in Complex Workplace Investigations Jul 15 2025 Loper Bright: Has the Demise of Chevron Deference Mattered? Print
